ATE249225T1 - Mannose-6-phosphat enthaltendes mittel und dessen verwendung bei der behandlungfibrotischer erkrankungen - Google Patents

Mannose-6-phosphat enthaltendes mittel und dessen verwendung bei der behandlungfibrotischer erkrankungen

Info

Publication number: ATE249225T1
Authority: AT; Austria
Prior art keywords: phosphate; treatment; agent containing; fibrotic diseases; containing mannose
Prior art date: 1996-08-12

Application number

AT97934624T

Other languages

English (en)

Inventor

Mark William James Ferguson

Original Assignee

Btg Int Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-08-12

Filing date

1997-07-31

Publication date

2003-09-15

1997-07-31 Application filed by Btg Int Ltd filed Critical Btg Int Ltd

2003-09-15 Application granted granted Critical

2003-09-15 Publication of ATE249225T1 publication Critical patent/ATE249225T1/de

Links

NBSCHQHZLSJFNQ-QTVWNMPRSA-N D-Mannose-6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@@H]1O NBSCHQHZLSJFNQ-QTVWNMPRSA-N 0.000 title abstract 2
239000003795 chemical substances by application Substances 0.000 title 1
201000010099 disease Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
230000003176 fibrotic effect Effects 0.000 title 1
239000000725 suspension Substances 0.000 abstract 2
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 1
239000000499 gel Substances 0.000 abstract 1
229920002674 hyaluronan Polymers 0.000 abstract 1
229960003160 hyaluronic acid Drugs 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
238000010979 pH adjustment Methods 0.000 abstract 1
230000036573 scar formation Effects 0.000 abstract 1
230000029663 wound healing Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Ophthalmology & Optometry (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Gastroenterology & Hepatology (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Inorganic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Materials For Medical Uses (AREA)

AT97934624T 1996-08-12 1997-07-31 Mannose-6-phosphat enthaltendes mittel und dessen verwendung bei der behandlungfibrotischer erkrankungen ATE249225T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9616896.8A GB9616896D0 (en)	1996-08-12	1996-08-12	Pharmaceutical compositions
PCT/GB1997/002076 WO1998006406A1 (en)	1996-08-12	1997-07-31	Mannose-6-phosphate composition and its use in treating fibrotic disorders

Publications (1)

Publication Number	Publication Date
ATE249225T1 true ATE249225T1 (de)	2003-09-15

Family

ID=10798358

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97934624T ATE249225T1 (de)	1996-08-12	1997-07-31	Mannose-6-phosphat enthaltendes mittel und dessen verwendung bei der behandlungfibrotischer erkrankungen

Country Status (12)

Country	Link
EP (1)	EP0921806B1 (de)
JP (2)	JP4971534B2 (de)
AT (1)	ATE249225T1 (de)
AU (1)	AU721224B2 (de)
CA (1)	CA2261988C (de)
DE (1)	DE69724798T2 (de)
DK (1)	DK0921806T3 (de)
ES (1)	ES2206737T3 (de)
GB (1)	GB9616896D0 (de)
PT (1)	PT921806E (de)
WO (1)	WO1998006406A1 (de)
ZA (1)	ZA977151B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9616896D0 (en) *	1996-08-12	1996-09-25	British Tech Group	Pharmaceutical compositions
WO2004031379A1 (en) *	2002-10-01	2004-04-15	Unilever N.V.	Proteins having polysaccharidase activity
US9517023B2 (en)	2009-06-01	2016-12-13	Profusa, Inc.	Method and system for directing a localized biological response to an implant
GB0910078D0 (en) *	2009-06-11	2009-07-22	Renovo Ltd	Uses of mannose-6-phosphate
GB0916333D0 (en)	2009-09-17	2009-10-28	Renovo Ltd	Improvement of tendon repair
US10010272B2 (en)	2010-05-27	2018-07-03	Profusa, Inc.	Tissue-integrating electronic apparatus
JP5827999B2 (ja)	2010-10-06	2015-12-02	プロフューザ，インコーポレイティド	組織集積センサー
CN113274007B (zh)	2013-03-14	2024-10-18	普罗菲尤萨股份有限公司	用于校正光学信号的方法和装置
WO2014197786A2 (en)	2013-06-06	2014-12-11	Kintz Gregory J	Apparatus and methods for detecting optical signals from implanted sensors
US11331018B2 (en)	2016-12-22	2022-05-17	Profusa, Inc.	System and single-channel biosensor for and method of determining analyte value
GB201904469D0 (en)	2019-03-29	2019-05-15	Givaudan Sa	Cosmetic composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5244651A (en) *	1991-09-04	1993-09-14	Kao Corporation	Method of desensitizing hypersensitive dentin
GB9205800D0 (en) *	1992-03-17	1992-04-29	British Tech Group	Treatment of fibrotic disorders
GB9616896D0 (en) *	1996-08-12	1996-09-25	British Tech Group	Pharmaceutical compositions

1996
- 1996-08-12 GB GBGB9616896.8A patent/GB9616896D0/en active Pending
1997
- 1997-07-31 DE DE69724798T patent/DE69724798T2/de not_active Expired - Lifetime
- 1997-07-31 CA CA002261988A patent/CA2261988C/en not_active Expired - Fee Related
- 1997-07-31 PT PT97934624T patent/PT921806E/pt unknown
- 1997-07-31 ES ES97934624T patent/ES2206737T3/es not_active Expired - Lifetime
- 1997-07-31 AU AU37769/97A patent/AU721224B2/en not_active Ceased
- 1997-07-31 AT AT97934624T patent/ATE249225T1/de active
- 1997-07-31 EP EP97934624A patent/EP0921806B1/de not_active Expired - Lifetime
- 1997-07-31 JP JP50947298A patent/JP4971534B2/ja not_active Expired - Fee Related
- 1997-07-31 WO PCT/GB1997/002076 patent/WO1998006406A1/en not_active Ceased
- 1997-07-31 DK DK97934624T patent/DK0921806T3/da active
- 1997-08-11 ZA ZA977151A patent/ZA977151B/xx unknown
2009
- 2009-05-29 JP JP2009129987A patent/JP2009221220A/ja active Pending

Also Published As

Publication number	Publication date
WO1998006406A1 (en)	1998-02-19
ZA977151B (en)	1999-02-11
DE69724798T2 (de)	2004-07-15
JP2000516603A (ja)	2000-12-12
DK0921806T3 (da)	2003-12-08
JP2009221220A (ja)	2009-10-01
JP4971534B2 (ja)	2012-07-11
EP0921806B1 (de)	2003-09-10
EP0921806A1 (de)	1999-06-16
ES2206737T3 (es)	2004-05-16
PT921806E (pt)	2003-12-31
GB9616896D0 (en)	1996-09-25
DE69724798D1 (de)	2003-10-16
AU3776997A (en)	1998-03-06
CA2261988A1 (en)	1998-02-19
CA2261988C (en)	2006-11-07
AU721224B2 (en)	2000-06-29

Similar Documents

Publication	Publication Date	Title
DE69929810D1 (de)	2006-04-20	Verwendung von tetracyclinderivaten zur steigerung der interleukin-10 produktion
DE69013833D1 (de)	1994-12-08	Zusammensetzung und methode zur verhütung von verklebungen zwischen körpergewebe.
ATE227587T1 (de)	2002-11-15	Kombinierte verwendung von hyaluronsäure und therapeutischen wirkstoffen zur verbesserung des therapeutischen effekts
PA8447801A1 (es)	2000-05-24	Derivados del acido hexanoico
ATE347585T1 (de)	2006-12-15	In-vitro wachstum von langerhans'schen inseln und ihre verwendungen
DE69627467D1 (de)	2003-05-22	Verwendung von zusammensetzungen mit benzoylperoxyd, glycolsäure und zink zur behandlung von dermatologischen krankheiten
DE69527765D1 (de)	2002-09-19	Verwendung von Hyaluronsäure oder sein Salz zur Behandlung von Hauterkrankungen
DE69724798D1 (de)	2003-10-16	Mannose-6-phosphat enthaltendes mittel und dessen verwendung bei der behandlungfibrotischer erkrankungen
ATE311853T1 (de)	2005-12-15	Verwendung von krillenzymen zur behandlung von zahnbelag
ATE196847T1 (de)	2000-10-15	Verwendung von mannosephosphaten zur behandlung von fibrotischen störungen
ATE330613T1 (de)	2006-07-15	Verwendung von prostaglandin a oder dessen derivaten zur behandlung von psoriasis
DE69419640D1 (de)	1999-09-02	Pharmakologische Verwendung von 5-Aminophthaloylhydrazide; ihre Zusammensetzung und Anwendung
DE69833937D1 (de)	2006-05-11	Verwendung von zinkhyaluronat gegen magengeschwür
PT862452E (pt)	2004-04-30	Formulacao de estabilizacao para o ngf
MX9701187A (es)	1997-05-31	Nuevas lactamas naftofusionadas n-substituidas.
AU2388392A (en)	1993-02-23	Oxicam or oxicam derivatives-containing ophthalmic compositions
ES2154290T3 (es)	2001-04-01	Estimulacion de la diferenciacion celular por sindecano.
IL138950A0 (en)	2001-11-25	Stable compositions comprising levosimendan and alginic acid
ATE225181T1 (de)	2002-10-15	Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen
DE69127767D1 (de)	1997-11-06	Verwendung von Hexetidin oder dessen Derivaten oder Salzen zur Herstellung einer pharmazeutischen Zusammensetzung für ophthalmische Verwendung
ATE248218T1 (de)	2003-09-15	Humane hypertrophe chrondrozyten zelllinien
DE69907685D1 (de)	2003-06-12	Verwendung von derivaten von tetrahydropyridinen oder (4-hydroxypiperidin)-butylazolen zur herstellung von präparaten zur schmerzbehandlung
HUP9802142A2 (hu)	1999-04-28	Na+/H+ -ioncsere inhibítorok alkalmazása a központi idegrendszer betegségeinek kezelésére és megelőzésére alkalmas gyógyszerkészítmények előállítására
MXPA02004704A (es)	2004-09-10	Analogos de acido hidroxieicosatetraenoico y sus metodos de uso en el tratamiento de trastornos de resequedad del ojo.
DE3579476D1 (de)	1990-10-11	Haarwuchsstimulierende mittel und deren verwendung.

Legal Events

Date

Code

Title

Description

2004-01-15

UEP

Publication of translation of european patent specification

Ref document number: 0921806

Country of ref document: EP